title: Chemical safety and health conditions among Hungarian hospital nurses.
abstract: In the present study genotoxicological and immunotoxicological follow-up investigations were made on 811 donors including 94 unexposed controls and 717 nurses with various working conditions from different hospitals (The Hungarian Nurse Study). The nurses were exposed to different chemicals: cytostatic drugs, anesthetic, and sterilizing gases, such as ethylene oxide (ETO) and formaldehyde. The measured biomarkers were: clinical laboratory routine tests, completed with genotoxicological (chromosome aberrations [CA], sister chromatid exchange [SCE]), and immune-toxicological monitoring (ratio of lymphocyte subpopulations, lymphocyte activation markers, and leukocyte oxidative burst). The highest rate of genotoxicologically affected donors (25.4%) was found in the group of cytostatic drug-exposed nurses. Comparing geno- and immunotoxicological effect markers, we found that among genotoxicologically affected donors the frequency of helper T cell (Th) lymphocytes, the ratio of activated T and B cells increased, whereas the oxidative burst of leukocytes decreased. In hospitals with lack of protective measures increased CA yields were observed compared to those with ISO 9001 quality control or equivalent measures. Anemia, serum glucose level, thyroid dysfunctions, benign, and malignant tumors were more frequent in the exposed groups than in controls. The hygienic standard of the working environment is the basic risk factor for the vulnerability of nurses. On the basis of these results, it is suggested, that the used cytogenetic and immunological biomarkers are appropriate to detect early susceptibility to diseases. The Hungarian Nurse Study proved that the use of safety measures could protect against occupational exposure at work sites handling cytostatic drugs, anesthetic, and sterilizing gases.
authors.affiliation: Department of Public Health, Semmelweis University, P.O. Box 370, 1445 Budapest, Hungary. tompa.okbi@okk.antsz.hu
authors.forename: Anna
authors.initials: A
authors.lastname: Tompa
authors.forename: Mátyás
authors.initials: M
authors.lastname: Jakab
authors.forename: Anna
authors.initials: A
authors.lastname: Biró
authors.forename: Balázs
authors.initials: B
authors.lastname: Magyar
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Fodor
authors.forename: Tibor
authors.initials: T
authors.lastname: Klupp
authors.forename: Jenö
authors.initials: J
authors.lastname: Major
mesh_terms: D005434:Flow Cytometry; D015386:Hazardous Substances; D006801:Humans; D006814:Hungary; D007107:Immune System / Q000187:drug effects; D016130:Immunophenotyping; D009153:Mutagens / Q000633:toxicity; D009741:Nursing Staff, Hospital; D016897:Respiratory Burst
chemical_list: D015386:Hazardous Substances; D009153:Mutagens